{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T17:26:03Z","timestamp":1777483563166,"version":"3.51.4"},"reference-count":31,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T00:00:00Z","timestamp":1582848000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Clinical Hypertension"],"published-print":{"date-parts":[[2020,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This paper proposes a costing tool for hypertension and cardiovascular disease by adapting cost\u2010of\u2010illness methodologies to estimate the attributable burden of excessive salt intake on cardiovascular disease. The methodology estimates the changes in blood pressure that result from each gram change in salt intake and links diet to the direct and indirect costs of cardiovascular diseases (CVD), such as coronary heart disease, stroke, hypertensive disease, aortic aneurysm, heart failure, pulmonary embolism, and rheumatic heart, using the relative risks of disease and the prevalence of salt consumption in the population. The methodology includes (a) identifying major diseases and conditions related to excessive salt intake and relevant economic cost data available, (b) quantifying the relationship between the prevalence of excessive salt intake and the associated risk of disease morbidity and mortality using population attributable risks (PAR), (c) using PARs to estimate the share of total costs directly attributed to excessive salt intake, and (d) undertaking a sensitivity analysis of key epidemiological and economic parameters. The costing tool has estimated that, in 2013, US$ 102.0\u00a0million (95% uncertainty interval\u2014UI: US$ 96.2\u2010107.8\u00a0million) in public hospitalizations could be saved if the average salt intake of Brazilians were reduced to 5\u00a0g\/d, corresponding to 9.4% (95% UI: 8.9%\u20109.9%) of the total hospital costs by CVDs. This methodology of cost of illness associated with salt consumption can be adapted to estimate the burden of other dietary risk factors and support prevention and control policies in Brazil and in other countries.<\/jats:p>","DOI":"10.1111\/jch.13836","type":"journal-article","created":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T14:25:07Z","timestamp":1582899907000},"page":"642-648","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Developing and applying a costing tool for hypertension and related cardiovascular disease: Attributable costs to salt\/sodium consumption"],"prefix":"10.1111","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2650-4878","authenticated-orcid":false,"given":"Eduardo Augusto Fernandes","family":"Nilson","sequence":"first","affiliation":[{"name":"School of Public Health University of Sao Paulo Sao Paulo Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Everton N.","family":"da Silva","sequence":"additional","affiliation":[{"name":"Department of Economics University of Brasilia Brasilia Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patr\u00edcia C.","family":"Jaime","sequence":"additional","affiliation":[{"name":"School of Public Health University of Sao Paulo Sao Paulo Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2020,2,28]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)30041-8"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-017-0216-2"},{"key":"e_1_2_9_4_1","doi-asserted-by":"crossref","unstructured":"ToddPE WolpinKI.Ex ante evaluation of social programs;2008.https:\/\/doi.org\/10.2307\/27917248","DOI":"10.2307\/27917248"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12963-016-0085-1"},{"issue":"3","key":"e_1_2_9_6_1","first-page":"241","article-title":"The economic burden of hypertension, heart failure, myocardial infarction, and atrial fibrillation in Mexico","volume":"88","author":"Stevens B","year":"2018","journal-title":"Arch Cardiol Mex"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.118.12606"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-018-5806-x"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/748750"},{"issue":"4","key":"e_1_2_9_10_1","first-page":"1","article-title":"Direct healthcare cost of obesity in Brazil: an application of the cost\u2010of\u2010illness method from the perspective of the public health system in 2011","volume":"10","author":"De OML","year":"2015","journal-title":"PLoS ONE"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0203992"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1590\/S0034-8910.2015049006211"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.008727"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)30467-6"},{"key":"e_1_2_9_15_1","first-page":"CD004022","article-title":"Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride","volume":"4","author":"Graudal NA","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/jch.12437"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/jch.13664"},{"issue":"9","key":"e_1_2_9_18_1","first-page":"1","article-title":"Dietary reference values for sodium","volume":"17","author":"EFSA Panel on Nutrition Novel Foods and Food Allergens (NDA)","year":"2019","journal-title":"EFSA J"},{"key":"e_1_2_9_19_1","volume-title":"Dietary Reference Intakes for Sodium and Potassium","author":"National Academies of Sciences Engineering and Medicine","year":"2019"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0177535"},{"issue":"1","key":"e_1_2_9_21_1","first-page":"29","article-title":"The economic burden of heart conditions in Brazil","volume":"111","author":"Stevens B","year":"2018","journal-title":"Arq Bras Cardiol"},{"issue":"1","key":"e_1_2_9_22_1","first-page":"39","article-title":"Analysis of the economic impact of cardiovascular diseases in the last five years in Brazil","volume":"109","author":"Siqueira ASE","year":"2017","journal-title":"Arq Bras Cardiol"},{"key":"e_1_2_9_23_1","doi-asserted-by":"crossref","unstructured":"UN General Assembly.United Nations Decade of Action on Nutrition (2016\u20102025);2016.https:\/\/doi.org\/10.1093\/oxfordhb\/9780199560103.003.0005","DOI":"10.1093\/oxfordhb\/9780199560103.003.0005"},{"key":"e_1_2_9_24_1","unstructured":"World Health Organization (WHO).\u2018Best Buys\u2019 and other recommended interventions for the prevention and control of noncommunicable diseases.2017;(2017)."},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1590\/1980-549720190009.supl.2"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1590\/1415-52732014000500007"},{"key":"e_1_2_9_27_1","doi-asserted-by":"crossref","unstructured":"EvansD EdejerTTT ChisholmD StancioleA.WHO guide to identifying the economic consequences of disease and injury.2009. doi:https:\/\/doi.org\/10.1073\/pnas.1400475111","DOI":"10.1073\/pnas.1400475111"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0065174"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f1325"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)11911-8"},{"key":"e_1_2_9_31_1","unstructured":"BarendregtJJ.Ersatz user guide;2017.http:\/\/www.epigear.com\/index_files\/ErsatzUserGuide.pdf"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2014.20.4.327"}],"container-title":["The Journal of Clinical Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjch.13836","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jch.13836","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jch.13836","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jch.13836","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T23:02:35Z","timestamp":1694041355000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jch.13836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,28]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["10.1111\/jch.13836"],"URL":"https:\/\/doi.org\/10.1111\/jch.13836","archive":["Portico"],"relation":{},"ISSN":["1524-6175","1751-7176"],"issn-type":[{"value":"1524-6175","type":"print"},{"value":"1751-7176","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,28]]},"assertion":[{"value":"2019-11-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-02-06","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-02-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}